Typical target molecules, such as epidermal growth factor receptor (EGFR), human epidermal growth factor receptor type 2 (HER2), fibroblast growth factor receptor (FGFR), are mutated or amplified in only about 20% of head and neck cancers.5 Here, EGFR is linked to head and neck cancer.